Patrick Soon Shiong made his fortune revolutionizing cancer treatment. In 1991, he patented the drug Abraxane, a top-selling treatment that, despite being only a slight variation on the existing cancer drug Taxol, has made him the majority of his nearly $13.3 billion in net worth. Abraxane is an injectible form of the tree-bark-derived Taxol, packaged in a protein coat that makes it more efficient at targeting cancer cells. It's widely used to treat breast and lung cancers, and is now being recommended in patients with pancreatic cancer.
Soon-Shiong isn't just a doctor. He's also a businessman and he has started a company named NantHealth. In the first week of December 2014, Soon-Shiong rolled out the first part of the initiative, a mobile browser that would let doctors use a smartphone to look at their patients' genomes. This could have implications not just for cancer patients, but…
